New developments in the medical management of overactive bladder

作者：Robinson Dudley^*; Giarenis Ilias; Cardozo Linda

来源：Maturitas, 2013, 76(3): 225-229.

DOI：10.1016/j.maturitas.2013.07.003

• Overactive bladder
• Drug therapy
• Antimuscarinics
• Beta 3 agonists

Overactive bladder (OAB) is a clinical syndrome describing the symptom complex of urgency, with or without urgency incontinence and is usually associated with frequency and nocturia. Whilst the majority of women will benefit from initial management with conservative and behavioural intervention a significant number will require medical therapy. Antimuscarinics are currently the most widely prescribed drugs for OAB although very often persistence with medication is limited due to lack of efficacy or intolerable adverse effects.
The review, whilst giving a brief overview of OAB syndrome, will focus on new developments in drug therapy for OAB. In addition to evaluating new drugs with different methods of action it will also specifically focus on alternative modalities of treatment and how they may benefit patients with this troublesome and distressing condition.

• 出版日期2013-11